These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9602952)

  • 1. Urine drug screening results from volunteers in phase I clinical pharmacology studies: are we being misled?
    Ramey KL; Kovacs SJ; Martin DE; Jorkasky DK
    J Clin Pharmacol; 1998 May; 38(5):413-6. PubMed ID: 9602952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interference of common household chemicals in immunoassay methods for drugs of abuse.
    Warner A
    Clin Chem; 1989 Apr; 35(4):648-51. PubMed ID: 2539273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and predictors of screen failures due to positive urine tests for alcohol, drugs of abuse, and cotinine among normal healthy research volunteers (NHRVs): analysis of data from 687 NHRVs screened at a large clinical pharmacology unit in the United States.
    Nada A; Baxter S; Loraas E; Somberg JC
    Am J Ther; 2008; 15(3):214-20. PubMed ID: 18496258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multiple-site laboratory evaluation of three on-site urinalysis drug-testing devices.
    Crouch DJ; Frank JF; Farrell LJ; Karsch HM; Klaunig JE
    J Anal Toxicol; 1998 Oct; 22(6):493-502. PubMed ID: 9788525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the triage system for emergency drugs-of-abuse testing in urine.
    Wu AH; Wong SS; Johnson KG; Callies J; Shu DX; Dunn WE; Wong SH
    J Anal Toxicol; 1993; 17(4):241-5. PubMed ID: 8371556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urine drugs of abuse testing at the point-of-care: clinical interpretation and programmatic considerations with specific reference to the Syva Rapid Test (SRT).
    Yang JM; Lewandrowski KB
    Clin Chim Acta; 2001 May; 307(1-2):27-32. PubMed ID: 11369333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of ELISA screening for the monitoring of abstinence from illegal and legal drugs in hair and urine.
    Agius R; Nadulski T
    Drug Test Anal; 2014 Jun; 6 Suppl 1():101-9. PubMed ID: 24817055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of glutaraldehyde adulteration of urine specimens on syva EMIT II drugs-of-abuse assays.
    George S; Braithwaite RA
    J Anal Toxicol; 1996; 20(3):195-6. PubMed ID: 8735202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescence polarization immunoassay evaluated for screening for amphetamine and methamphetamine in urine.
    Caplan YH; Levine B; Goldberger B
    Clin Chem; 1987 Jul; 33(7):1200-2. PubMed ID: 3297420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Triage PPY on-site testing device for the detection of dextropropoxyphene in urine.
    Poklis A; Poklis JL; Tarnai LD; Backer RC
    J Anal Toxicol; 2004 Sep; 28(6):485-8. PubMed ID: 15516300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance evaluation of four on-site drug-testing devices for detection of drugs of abuse in urine.
    Peace MR; Tarnai LD; Poklis A
    J Anal Toxicol; 2000 Oct; 24(7):589-94. PubMed ID: 11043664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Retrospective Analysis of Urine Drugs of Abuse Immunoassay True Positive Rates at a National Reference Laboratory.
    Johnson-Davis KL; Sadler AJ; Genzen JR
    J Anal Toxicol; 2016 Mar; 40(2):97-107. PubMed ID: 26668238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interference of herbal drinks with urinalysis for drugs of abuse.
    Winek CL; Elzein EO; Wahba WW; Feldman JA
    J Anal Toxicol; 1993; 17(4):246-7. PubMed ID: 8371557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the ETS and ADx urine drug screening immunoassay analyzers.
    Edinboro LE; Hall KV; Poklis A
    J Anal Toxicol; 1989; 13(4):232-4. PubMed ID: 2779176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recreational drug use at a major music festival: trend analysis of anonymised pooled urine.
    Hoegberg LCG; Christiansen C; Soe J; Telving R; Andreasen MF; Staerk D; Christrup LL; Kongstad KT
    Clin Toxicol (Phila); 2018 Apr; 56(4):245-255. PubMed ID: 28814125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An investigation into the extent of possible dilution of specimens received for urinary drugs of abuse screening.
    George S; Braithwaite RA
    Addiction; 1995 Jul; 90(7):967-70. PubMed ID: 7663318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. False-negative results in the immunoassay analysis of drugs of abuse: can adulterants be detected by sample check test?
    Matriciani B; Huppertz B; Keller R; Weiskirchen R
    Ann Clin Biochem; 2018 May; 55(3):348-354. PubMed ID: 28728424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interference by nonsteroidal anti-inflammatory drugs in EMIT and TDx assays for drugs of abuse.
    Joseph R; Dickerson S; Willis R; Frankenfield D; Cone EJ; Smith DR
    J Anal Toxicol; 1995; 19(1):13-7. PubMed ID: 7723297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of RapiTest with Emit d.a.u. and GC-MS for the analysis of drugs in urine.
    Korte T; Pykäläinen J; Lillsunde P; Seppälä T
    J Anal Toxicol; 1997; 21(1):49-53. PubMed ID: 9013293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening of several drugs of abuse in Italian workplace drug testing: performance comparisons of on-site screening tests and a fluorescence polarization immunoassay-based device.
    Basilicata P; Pieri M; Settembre V; Galdiero A; Della Casa E; Acampora A; Miraglia N
    Anal Chem; 2011 Nov; 83(22):8566-74. PubMed ID: 21992470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.